Qi Yan

Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial

Egbert F. Smit, Enriqueta Felip, Dipesh Uprety et al. · The Lancet Oncology · 2024 · 123 citations · Full text

Oncology, Primary Results, Her2-overexpressing Cohorts +9

Discovery of 5-(methylthio)pyrimidine derivatives as L858R/T790M mutant selective epidermal growth factor receptor (EGFR) inhibitors

Qiang Xiao, Rong Qu, Dingding Gao et al. · Bioorganic & Medicinal Chemistry · 2016 · 31 citations · Full text

Medicine, Molecular Biology, Pharmacology +2

Quinoline-based hydrophilic flavonol fluorescent probe for specific and sensitive detection of Zn2+

Shasha Wu, Qi Yan, Yu Wang et al. · Microchemical Journal · 2024 · 28 citations

Sensitive Detection, Engineering, Biochemistry +7

Novel Azetidine-Containing TZT-1027 Analogues as Antitumor Agents

Qi Yan, Yujie Wang, Wei Zhang et al. · Marine Drugs · 2016 · 18 citations · Full text

Medicinal Chemistry, Pharmaceutical Science, Hct116 Cell Lines +13

Discovery of novel 2,4-diarylaminopyrimidine derivatives as potent and selective epidermal growth factor receptor (EGFR) inhibitors against L858R/T790M resistance mutation

Qi Yan, Yuzhe Chen, Baiyou Tang et al. · European Journal of Medicinal Chemistry · 2018 · 13 citations · Full text

Medicinal Chemistry, L858r/t790m Resistance Mutation, Drug Target +10